0.20Open0.20Pre Close0 Volume86 Open Interest20.00Strike Price0.00Turnover112.47%IV16.83%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type0.1661Delta0.1034Gamma86.45Leverage Ratio-0.0535Theta0.0004Rho14.36Eff Leverage0.0053Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet